Madhav V. Dhodapkar MBBS
Arthur H. Bunker and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Chief, Section of Hematology, Department of Internal Medicine; Clinical Research Program Leader, Hematology Program, Yale Cancer Center
Departments & Organizations
Yale Combined Program in the Biological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and Physiology
Yale Medical Group
Office of Student ResearchCancer Center, Yale: Hematology Program; Cancer Immunology; Dhodapkar LabImmunobiology: HTIHematology | National Gaucher Disease Treatment Center
Myeloma and related plasma cell disorders; Human immune system's interaction with growing tumors in patients; Preneoplastic monoclonal gammopathy and multiple myeloma, tumor and host related factors more...
- M.B.B.S., All India Institute of Medical Sciences, New Delhi, 1987
- Dhodapkar K, Banerjee D, Connolly J, Kukreja A, Matayeva E, Veri MC, Ravetch JV, Steinman RM, Dhodapkar MV. Selective blockade of the inhibitory FC-receptor (Fc-RIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med. 2007, 204: 1359-1369.
- Spisek R, Kukreja A, Chen L, Matthews P, Mazumder A, Vesole D, Jagannath S, Zebroski HA, Simpson AJG, Ritter G, Durie B, Crowley J, Shaughnessy Jr. JD, Scanlan M, Gure AO, Barlogie B, Dhodapkar MV. Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. J Exp Med. 2007, 204: 831-840.
- Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath, Dhodapkar MV. Bortezomib enhances dendritic cell mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: Therapeutic implications. Blood. 2007, 109: 4839-4845.